All posts by imreal

20% Discount on Daily Dog Walking Services For Frontliners


“We want to show gratitude to our frontline workers by giving them special pricing. We know that they’re serving long hours during these unprecedented times, and we don’t want their pets to be all alone.” – Joanna Price, Woofin’ It Owner & Lead Pet Concierge

In honor of our frontline workers, Woofin’ It, a pet concierge company, is exclusively offering a 20% discount on its Daily Dog Walking Services to all everyday heroes. Effective immediately, frontline workers and their fur babies get to enjoy one on one dog walking, starting at a special rate of $20 per 30 minutes.

Woofin’ It offers one on one dog walking services, cat care, and pet sitting in all areas of Frederick, and the surrounding area. Prices start from $25 per 30 minutes, with add-ons for weekends and holiday services. The company also offers vacation support (when the fur parent is away), and friendly client agreements for last-minute requests.

“We want to show gratitude to our frontline workers by giving them special pricing. We know that they’re serving long hours during these unprecedented times, and we don’t want their pets to be all alone.” –Joanna Price, Woofin’ It Owner & Lead Pet Concierge    

The company aims to give back for the courage and support that frontline employees show during trying times, and all times. Woofin’ It wants to be there for our frontliners, and give them some peace of mind about their pets’ health while they’re away.

Woofin’ It’s Commitment to Your Furry Friends

Woofin’ It is a full-time pet concierge company that vows to provide personal and loving care to your furry pals. It is fully bonded and insured by Pet Care Insurance. The Woofin’ It family is made of pet volunteers and rescuers who have a personal mission to build a long lasting bond with you and your pet.

Woofin’ It’s founder, Joanna Price, independently started this Pet Concierge company in February 2017. Since then, the business has grown into a team of five members, and has expanded its services to the Frederick areas of Baker Park, Walkersville, Clover Hill, and Whittier and more. Aside from running the business, Woofin’ It’s team members are also involved in volunteering for local shelters or organizations. Each member also has her own rescued pets.

Woofin’ It has an updated price catalogue for its services on their website, available on demand. For bookings and reservations, visit https://woofinitdogwalking.com/. You may also reach them at 301-639-2299. For other inquiries and concerns, shoot them an email at info@woofinitdogwalking.com.

Share article on social media or email:

UofL immunologist discovers biomarker warning of cellular crisis that could cause death in COVID-19 patients


Diagram showing levels of neutrophil immune cells (red dots) in a healthy donor, a patient with moderate COVID-19 and a patient with severe COVID-19. Data analysis by Corey T. Watson, Ph.D., David Tieri, Ph.D., and M.D./Ph.D. student Anne Geller.

Diagram showing levels of neutrophil immune cells (red dots) in a healthy donor, a patient with moderate COVID-19 and a patient with severe COVID-19

“Identifying patients who are trending toward a cellular crisis and then implementing early, appropriate treatment could improve mortality rates for severe COVID-19 patients,” said Jun Yan, M.D., Ph.D.

Jun Yan, M.D., Ph.D., professor of surgery and microbiology and immunology at the University of Louisville, led a team of researchers in the discovery of an important biomarker that predicts a crisis in COVID-19 patients that could lead to death.

Yan, an immunologist and researcher with the UofL Health – James Graham Brown Cancer Center, along with UofL Professor of Anesthesiology Jiapeng Huang, M.D., Ph.D., and M.D./Ph.D. student Samantha Morrissey, Ph.D., conducted a patient study to better understand the most severe cases of COVID-19.

Approximately 20 percent of COVID-19 patients experience severe disease, including pneumonia and acute respiratory distress syndrome (ARDS). In some of these patients, the rapid influx of immune cells to the lungs to fight the infection leads to complications in the lung and blood coagulation disorders, resulting in heart attack, pulmonary embolism, stroke or deep vein thrombosis.

To better understand these serious complications, Yan’s team evaluated levels of various immune cells in blood samples of COVID-19 patients and compared those levels with those of healthy individuals. They discovered that one type of immune cells, low-density inflammatory neutrophils, became highly elevated in some patients whose condition became very severe. This elevation signaled a point of clinical crisis and increased likelihood of death within a few days.

Neutrophils are one type of immune cells that serve as the first line of defense in the body. When an individual acquires an infection, neutrophils rush to the site to clear the pathogen causing the infection. However, if their presence is persistent or there is a very high volume of cells at the site of infection, in this case the lungs, they can cause unwanted adverse effects. In the case of patients with severe COVID-19, a blood clotting disorder known as coagulopathy occurred, that can manifest as pulmonary embolism, heart attack or stroke.

The study, published online as a preprint, details shifting levels of these neutrophils and other immune cells through repeated blood samples from study participants, correlated with improvement or worsening of the patients’ condition. If clinicians could detect a rise in these cells, they may be able to provide therapy to prevent the potential life-threatening conditions associated with them.

“Based on this study, we believe that the low-density inflammatory band neutrophil population contributes to COVID-19-associated coagulopathy (CAC) and could be used as a clinical marker to monitor disease status and progression,” Yan said. “Identifying patients who are trending toward a cellular crisis and then implementing early, appropriate treatment could improve mortality rates for severe COVID-19 patients.”

To provide additional clinical options for physicians in addressing these crises, Yan is now working with other researchers at UofL to test potential therapies.

Share article on social media or email:

RapidScale Promotes Duane Barnes to Chief Operations Officer


Duane Barnes, Chief Operations Officer – RapidScale

His leadership has contributed to our major differentiators in the market, and we are thrilled to have an innovative and trusted leader who consistently delivers results.

RapidScale, a Cox Business company, announced today that Duane Barnes has been promoted to chief operations officer. In this role, Barnes is responsible for the company’s architecture, solutions engineering, service delivery, software engineering, and customer support operations. He has been in an interim capacity in this role since January of this year, and prior to that served as senior vice president of technology.

Barnes has 20 years of experience in cloud computing, virtualization, sales engineering, complex data center solutions, managing hosting projects, storage, Software as a Service (SaaS), networking, disaster recovery, security, and VoIP. Since joining RapidScale in 2016, Barnes has been instrumental in executing the company’s growth strategies. He has led his teams to accomplish pivotal milestones, including achieving an industry-leading average Net Promoter Score (NPS) of 80+, the development of an innovative single-pane-of-glass customer portal, and the growth of RapidScale’s dual headquarters in Raleigh, NC.

“Duane has been an integral part of RapidScale’s growth throughout the years, demonstrating an exceptional ability to grow market share and efficiently manage internal operations,” said RapidScale Chief Executive Officer Larry Steelman. “His leadership has contributed to our major differentiators in the market, and we are thrilled to have an innovative and trusted leader who consistently delivers results.”

Before joining RapidScale, Barnes held vice president, director, and other leadership roles in top-performing technology companies such as Windstream Hosted Solutions, Open-Xchange, and Intelisys. He also led teams at MPInet, PowerOne Communications, and the Walt Disney Company. He has obtained numerous industry certifications including Microsoft, Cisco, VMware, CompTIA, HP, and EMC.

“I’m honored to formally step into this new role with RapidScale and continue to work with the rest of the talented leadership team to drive success,” said Barnes. “We continue to focus on providing our clients access to their mission-critical applications from anywhere, anytime, and on any device. I couldn’t be more excited to remain a part of an organization that is committed to providing innovative managed cloud solutions and industry-leading customer care.”

About RapidScale

Flexible enough for the SMB and powerful enough for the enterprise, RapidScale, a Cox Business company, is a global managed cloud services provider helping organizations increase IT productivity, improve security, and empower remote workforces. Some organizations partner with RapidScale to manage portions of their IT, while others offload it all. Through our global network of data centers and our 24/7/365 high-touch support team, we obsess over creating an exceptional IT experience through a human approach to managed cloud. For more information on RapidScale, visit http://www.rapidscale.net.

Cox Communications owns Cox Business and is a facilities-based provider of voice, video, and data solutions for commercial customers. More information about Cox Communications, a wholly-owned subsidiary of Cox Enterprises, is available at http://www.cox.com.

Media Contact

Nikki Salazar

nikki.salazar@rapidscale.net

Share article on social media or email:

The Barnes Firm Oakland Injury Attorney Landon Vivian Provides Insight on COVID-19 Legal Cases to Protect Client’s Rights


The Barnes Firm injury attorney - wrongfully exposed to COVID-19 in California

The Barnes Firm coronavirus lawyers are representing and helping families who have been wrongfully exposed to the COVID-19 virus.

“Even given all the shelter-in-place orders, you really can’t wait when it comes to contacting a lawyer. Also, getting medical treatment can be a great hurdle for our clients and we are here to assist,” said Landon Vivian, injury attorney for The Barnes Firm in the Bay Area.

On ABC 7 News in the San Francisco Bay Area, one of The Barnes Firm’s best injury lawyers, Landon Vivian, explained how they’ve adapted to working through COVID-19 to protect client interests. The Barnes Firm coronavirus lawyers are representing and helping families who have been wrongfully exposed to the COVID-19 virus.

Many people who may have been exposed to COVID-19 in nursing homes, senior care centers, prisons, holding centers, and many other facilities have reached out to The Barnes Firm. Their COVID-19 lawyers are focusing on what was done and what could have been done reasonably to prevent that exposure from occurring, and that is a major focal point as they advance in these cases.

The Barnes Firm injury attorneys are here to answer any questions for family members who have lost a loved one to the Coronavirus:

  • Who’s responsible?
  • What can be done?
  • Why wasn’t my family protected from COVID-19?

Each county in California has different rules in place and The Barnes Firm will look to show where their client came into contact with the person who exposed them to COVID-19. Attorney Vivian mentions that each case is unique and it is important to gather all facts and conduct a proper investigation.

Attorney Landon Vivian advises not to wait when it comes to contacting a lawyer to advocate for your rights. They can also help with getting medical treatment to decrease disruption to cases.

“Even given all the shelter-in-place orders, you really can’t wait when it comes to contacting a lawyer. Also, getting medical treatment can be a great hurdle for our clients and we are here to assist,” said Landon Vivian, injury attorney for The Barnes Firm in the Bay Area.

Family members who’ve been wrongfully exposed to the coronavirus in nursing homes, senior care centers, holding centers, and other facilities can contact the experienced team at The Barnes Firm to help get the answers to their legal questions. For more information, please visit The Barnes Firm website.

About The Barnes Firm:

The Barnes Firm’s experienced personal injury attorneys focus exclusively on accident cases. They have helped thousands of injured victims get the best results possible with their settlements and verdicts.

The firm helps families across California, and has offices located in Los Angeles, Oakland, and San Diego.

In addition to legal services, The Barnes Firm stays involved in the community through its ongoing local philanthropy efforts. The California car accident lawyers sponsor academic organizations and nonprofits throughout the state. For more information, please visit https://www.thebarnesfirmcommunity.com/.

If you’ve been in an accident, you can count on The Barnes Firm Injury Attorneys to help. Please visit https://www.thebarnesfirm.com/. You can also find The Barnes Firm on Facebook, Instagram, Twitter, and LinkedIn.

Share article on social media or email:



SimpliFed Launches the First Tele-Lactation and Infant Nutrition Consulting Platform


The company’s mission is to help new mothers secure access to breastfeeding and infant nutrition support from the comfort and safety of their own homes from board-certified lactation consultants (IBCLCs).

SimpliFed logo: SimpliFed launches their services as the first independent tele-lactation consulting and nutrition support platform.

“I have been deeply troubled by the lack of support available for moms following births during COVID-19, which led to the founding of this new platform for moms seeking lactation and infant nutrition guidance,” said Andrea Ippolito, founder of SimpliFed.

SimpliFed, the first independent telehealth platform exclusively focused on infant feeding and nutrition, announced today that it has officially launched its services to help new parents navigate how best to feed their new baby in the comfort and safety of their own homes. The new platform launches amid social distancing measures, which impacts the practice of in-home lactation and infant nutrition guidance. SimpliFed was founded by a Cornell University faculty member and new mom in collaboration with her own lactation consultant. The mission of the platform is to empower each parent to make an educated decision to choose what works best for them and their baby whether that be breastmilk, infant formula, or a combination of both.

“I have been deeply troubled by the lack of support available for moms following births during COVID-19, which led to the founding of this new platform for moms seeking lactation and infant nutrition guidance,” said Andrea Ippolito, founder of SimpliFed. “We want to relieve moms of some of the stress in those first few days and weeks while they are home with their infant by helping them secure the lactation and nutrition support necessary for a healthy baby.”

Ippolito, who is also a Cornell University faculty member, committed to founding SimpliFed after reflecting on her own experience as a new mom facing breastfeeding challenges. When she was first home with her own child, she was able to easily work with lactation consultants, who typically provide care for new moms either in pediatric offices or via in-home care. More recently however, Ippolito realized that during a crisis such as COVID-19 and social distancing, most new mothers do not have the luxury of that experience. Ippolito was able to leverage insights that she gained during her Master’s program at MIT as she studied telehealth in the United States military and Department of Veterans Affairs, both of which were early adopters of telehealth.

SimpliFed provides telehealth access to board-certified lactation consultants (IBCLCs) to help new mothers navigate the various infant feeding options available to ultimately make the best personal choice. Lactation consultant appointments are booked with initial fees beginning at $30 for 20 minutes, with follow up appointments added as necessary by the mother. Reimbursement is often covered by the parents’ health insurer or their HSA/FSA program. Through the Affordable Care Act, all new health plans must cover both comprehensive prenatal and postnatal lactation support and counseling. Thus, breastfeeding mothers have coverage for lactation counseling without cost-sharing for as long as they are breastfeeding.

“Building on what we’ve learned so far, we continue to co-design and improve SimpliFed with the help and feedback of moms to meet the needs of new moms,” said Ippolito. “By remotely connecting lactation consultants to new mothers, SimpliFed is the next best thing to having a lactation consultant come to your home. We want to empower each parent to help them understand the best option available for them, to ultimately help them reach their baby’s feeding goals for their long-term health.”

More information about SimpliFed can be found: https://www.simplifed.us/.

ABOUT SIMPLIFED

SimpliFed is the first independent tele-lactation consulting and nutrition support platform connecting new mothers with resources in the first weeks of becoming a parent. The company’s mission is to help new mothers secure access to breastfeeding and infant nutrition support from the comfort and safety of their own homes from board-certified lactation consultants (IBCLCs). Founded by Andrea Ippolito, a Cornell University faculty member, who struggled with breastfeeding her own child, found the resources to decide what feeding options worked best for her and her baby, and realized that more mothers need access to lactation care, especially during times of crisis. The SimpliFed platform is accessible to new moms across the US, with lactation consultants available for appointment at the parents’ convenience. More information can be found at: https://www.simplifed.us/

Share article on social media or email:

PA Top Docs Proudly Presents May 2020 Approved Providers


PA Top Docs - May 2020

PA Top Docs – May 2020

PA Top Docs and PA Top Dentists are proud to feature the following May 2020 approved providers.

PA TOP DOCS INCLUDE:

ALLERGY, ASTHMA & IMMUNOLOGY

CARDIOLOGY

  • Dr. Venkatesh Nadar
  • Dr. Michael S. Nathanson
  • Dr. Gregg L. Neithardt
  • Dr. Prasant Pandey
  • Dr. Ted Parris
  • Dr. Elizabeth A. Piccione
  • Dr. Thomas B. Pinto

COLON & RECTAL SURGERY

ENT (OTOLARYNGOLOGY)

  • Dr. Ravindran Nadarajah
  • Dr. Gurston G. Nyquist
  • Dr. Michael A. Picariello

FAMILY PRACTICE

  • Dr. Nathan M. Moore
  • Dr. Bruce S. Morrison
  • Dr. Margaret S. Morton
  • Dr. Harry C. Myers
  • Dr. William P. Nasuti
  • Dr. Lawrence J. Nelson
  • Dr. Eric Newman
  • Dr. Beverly Niehls
  • Dr. Jennifer B. O’Connor
  • Dr. Chris M. O’Neil
  • Dr. Edmond Obeid
  • Dr. Rebecca J. Odorizzi
  • Dr. Emmanuel C. Okolo
  • Dr. Michele A. Oleksak
  • Dr. Cayce A. Onks
  • Dr. Glenn R. Ortley
  • Dr. John Pagnotto
  • Dr. Laura S. Pennings

GASTROENTEROLOGY

  • Dr. Louis F. Morsbach Jr.
  • Dr. Sudhir Narla
  • Dr. Rajesh R. Panchwagh

GENERAL SURGERY

  • Dr. Matthew Montgomery
  • Dr. Jan Anthony Olenginski
  • Dr. T. Kumar Pendurthi
  • Dr. Yeshwant G. Phadke

INTERNAL MEDICINE

  • Dr. Rajan Mulloth
  • Dr. Bichara C. Muvdi
  • Dr. Eileen P. Neely
  • Dr. Hang T. Nguyen
  • Dr. Cynthia M. Oleski
  • Dr. Michael C. Ong
  • Dr. Rashmikant Pandit
  • Dr. Maulikkumar Patel
  • Dr. Venkata R. Pericherla

NEPHROLOGY

  • Dr. Nimish S. Naik
  • Dr. Matthew G. Pesacreta

OB/GYN

  • Dr. Owen C. Montgomery
  • Dr. Lane A. Moskoff
  • Dr. Miles Murphy
  • Dr. Anand H. Noticewala
  • Dr. Melanie E. Ochalski
  • Dr. Joseph Orraca-Tetteh
  • Dr. Mary E. Pagan
  • Dr. Christine L. Phillips

ONCOLOGY / HEMATOLOGY

  • Dr. Kathryn A. Peroutka
  • Dr. Daniel Paul Petro

OPHTHALMOLOGY

  • Dr. Ananth V. Mudgil
  • Dr. Laura A. Pallan
  • Dr. Ravi D. Patel
  • Dr. Christopher Patitsas

ORTHOPEDIC SURGERY

  • Dr. Paul C. Neuman
  • Dr. Marcelino P. Oliveri
  • Dr. Meredith N. Osterman
  • Dr. A. Lee Osterman
  • Dr. Corey A. Pacek
  • Dr. Michael Pagnotto
  • Dr. Javad Parvizi

PEDIATRICS

  • Dr. David C. Mowery
  • Dr. Christine V. Nguyen
  • Dr. David J. Patton
  • Dr. Glenn H. Pisk

PLASTIC / COSMETIC SURGERY

  • Dr. Dennis T. Monteiro
  • Dr. Sameer Patel
  • Dr. Emily A. Peterson
  • Dr. John D. Potochny

RADIATION ONCOLOGY

VASCULAR SURGERY

—-

About Us

PA Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in Pennsylvania online in an easy to use format. PA Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

PA Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, e-mail us at info@PATopDocs.com and/or visit http://www.PATopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



NeoTract Designates Dr. C. Shawn West as UroLift® Center of Excellence


News Image

“We are proud to name Dr. C. Shawn West as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that C. Shawn West, M.D., McIver Clinic in Jacksonville, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. West has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. C. Shawn West as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allow physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

LifePlus previews its breakthrough smartwatch for people with prediabetes, hypertension & other chronic conditions


LifePlus - Turn Over a New Leaf

Turn Over a New Leaf

Creating a wearable specifically designed to reverse the effects of prediabetes has been our mission for over 5 years.

LifePlus, a next generation medical device company, previewed the breakthrough technology behind its flagship smartwatch that provides a continuous real time and truly non-invasive way to measure and monitor five different vitals including blood glucose. LifePlus CEO, Dr. Alodeep Sanyal, presented this preview in the DIABESTSMINE D-DATA EXCHANGE forum, held on June 12th in conjunction with the American Diabetes Association 80th Annual Scientific Sessions.

Dr. Sanyal stated, “Research shows almost everyone who develops Type 2 diabetes, develops prediabetes first. But not everyone who has prediabetes ends up with diabetes. Prediabetes can be reversed if acted upon early and carefully. Creating a wearable specifically designed to reverse the effects of prediabetes has been our mission for over 5 years.”

“Our goal is to provide the world’s first, truly non-invasive wearable for continuous tracking of blood glucose, eliminating painful finger sticks.” Dr. Sanyal adds, “Our wearable will continuously & non-invasively track blood glucose, blood pressure, heart rate, heart rate variability, oxygen saturation and respiration rate providing a comprehensive, ‘360º’ view of your metabolic and cardiovascular health.”

After the presentation Dr. Sanyal engaged in a lively Q&A session with attendees answering questions about LifePlus’ initial focus on prediabetes, availability of their open API to integrate with other diabetes management solutions, and how people can participate in early trials.

The first version of the LifeLeaf product will be available this fall through Hovid Pharmaceuticals in Malaysia and other South-East Asian markets. US availability will follow FDA approval which is currently in progress.

About LifePlus

LifePlus is a Silicon Valley, California based technology company that develops and manufactures next generation connected and smart medical devices addressing long-standing medical challenges. Their flagship product, LifeLeaf, is a smartwatch that uses spectroscopic signals to measure five different vitals including blood glucose, blood pressure, heart rate, respiration rate and blood oxygen saturation. A continuous, real time and non-invasive measurement of these vitals provide functional and practical solutions for people suffering from chronic conditions, such as diabetes and hypertension. Learn more about LifePlus at http://www.lifeplus.ai.

Trademarks

LifeLeaf is a registered trademark of LifePlus, Inc.

Keywords

Diabetes, Blood Glucose, CGM, Glucometer, smartwatch

Share article on social media or email:

GoStork Expands Online Platform to Streamline Point-by-Point Search for Surrogacy Agencies


GoStork

“I created GoStork to simplify the complex infertility marketplace by putting all of the information, offerings, and ability to filter by personal preferences in a single location.” Eran Amir – Founder

GoStork, a technology company that enables intended parents to find, compare, and connect with fertility providers throughout the country, has announced the expansion of its online platform to include surrogacy agencies. Designed to help intended parents select providers that best fit their needs and budget, the site is the only one of its kind to offer a comprehensive set of options, including well-organized, consistent information that affords greater transparency for the industry.

GoStork.com’s original launch was in early 2020, beginning with a product enabling intended parents to find, compare, and connect egg donors from various donation agencies. There are now over 6,000 egg donors available on the platform – from various top agencies across the US. The recently added functionality of the surrogacy agency marketplace further expands the efficacy of the platform.

The new offering allows users to view comprehensive information about top surrogacy agencies and filter them by personal preferences. Each agency’s profile includes clear cost breakdowns, as well as answers to the questions most commonly posed by intended parents, including:

-Year the agency was founded

-Number of babies born via their services

-Average time it takes to match parents with surrogates

-Average time from contract-signing to baby’s birth

-Number of families simultaneously serviced by each surrogacy coordinator

-If services are offered to the LGBTQ community or international parents

A first-of-its-kind comparison tool then facilitates a side-by-side, point-by-point view of each agency’s offerings. Users can also learn more about unique features of the agency and virtually meet executive staff and case managers via short videos.

Since some surrogacy agencies offer more services than others, intended parents can easily review their options, including the availability of:

-An in-house attorney

-Escrow management

-Case management and education

-Counseling and support

-Medical billing management

-Support in establishing parental rights

-Fertility loans provided by third party

The platform also addresses the type of carrier screenings undertaken by each agency, such as:

-Criminal background check

-Medical and psychological pre-screening

-Social worker pre-screening

-Financial review of household income and economic stability

-Appropriate health insurance coverage

-Home visits by agency

Understanding what others have experienced when working with each agency is critical to prospective parents’ research. With this in mind, GoStork offers individual reviews by verified customers, as well as helpful overviews that average their ratings for:

-Length of time for the entire process

-Agency effectiveness and responsiveness

-How intended parents felt they were treated by agency staff

-Whether or not they would recommend the agency

Continuing GoStork’s focus on accessibility and convenience, the platform features a booking system that makes it easy for intended parents to set up their initial appointment with the agency of their choice. Once scheduled, the feature instantly books the time on both parties’ calendars. “I know from personal experience that when parents make the decision to expand their families via fertility providers, it’s a confusing and overwhelming task to try to find the information they need,” explains Eran Amir, company founder and CEO. “I created GoStork to simplify the complex infertility marketplace by putting all of the information, offerings, and ability to filter by personal preferences in a single location.”

States Sam Hyde, president of Circle Surrogacy in Boston, Massachusetts, one of GoStork’s launch partners, “The feature that impresses me the most about the GoStork platform is the transparency it provides for our industry. Selecting a surrogacy agency can be challenging, but thanks to GoStork intended parents can compare ratings, reviews and many other criteria across leading providers. I also appreciate the booking tool, which allows customers to make an appointment with us directly from GoStork.”

Over the next several months, Go Stork will add IVF clinics, sperm donors, and adoption agencies to the platform’s offerings.

About GoStork:

GoStork is the only online platform where intended parents can find, compare, and connect with egg donors, surrogacy agencies, and IVF clinics in a single process. GoStork leverages proprietary technology, paired with thorough human vetting, to establish and continuously expand the first-ever structured marketplace in the infertility industry. In doing so, GoStork creates much-needed transparency, reducing the amount of work and confusion people experience on their journey from infertility to parenthood. GoStork accomplishes this by featuring top fertility providers from across the country in one centralized location, enabling advanced searching and filtering by clients’ preferences. It additionally allows the side-by-side comparison of detailed cost breakdowns, success metrics, customer reviews, and many other key criteria to support informed decision-making. The product further enables the direct booking of appointments with customers’ preferred providers. GoStork works independently from any agency or clinic. For more information, visit GoStork.com or email contact@gostork.com.

Share article on social media or email:

Senior Pharmaceutical Drug Development Executive, Philip Chaikin, PharmD, MD, FCP, Joins NDA Partners as Expert Consultant


News Image

Dr. Chaikin’s expertise in pharmaceutical drug development strategy, regulatory strategy, clinical pharmacology, and experience interacting with FDA, EMA, and other European regulatory agencies will bring significant value to our drug development clients.

NDA Partners Chairman Carl Peck, MD, announced today that Dr. Philip Chaikin, a senior pharmaceutical industry executive with extensive drug development experience in development strategy, regulatory strategy, clinical pharmacology, and clinical study design, has joined the firm as an Expert Consultant. Throughout his 30 year career, Dr. Chaikin interacted with the US Food and Drug Administration (FDA), including the Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), European regulatory bodies, and the European Medicines Agency (EMA) and participated in FDA Advisory Committee Meetings in the cardiovascular, anesthesia/critical care, oncology, respiratory, and anti-infectives therapeutic areas. He also secured numerous global drug approvals including the development and launch of the blockbuster drugs: Lovenox®, Taxotere®, and Procardia XL®.

Dr. Chaikin formerly served as Executive Vice President for Drug Development and Head of International Drug Development at Kyowa Pharmaceuticals. Prior to this position, he served as Vice President of Clinical Research and Regulatory Affairs at Acumen Sciences, Vice President of Oncology R&D at Elan Pharmaceuticals, and Senior Vice President of Development at Pharmacologics. In addition, he served as Vice President of Worldwide Clinical Development at Rhone-Poulenc Rorer/Aventis Pharmaceuticals and Vice President of Clinical Development at Hoechst-Roussel Pharmaceuticals. In his early career, Dr. Chaikin served as Director of Clinical Pharmacology at Bristol-Myers Squibb, Senior Associate Medical Director at Pfizer, and Senior Research Scientist, Drug Metabolism and Pharmacokinetics at Ortho Pharmaceuticals.

“We are pleased to welcome Dr. Chaikin to NDA Partners,” said Dr. Carl Peck. “Dr. Chaikin’s expertise in pharmaceutical drug development strategy, regulatory strategy, clinical pharmacology, and experience interacting with FDA, EMA, and other European regulatory agencies will bring significant value to our drug development clients developing therapies in a wide range of therapeutic areas.”

Dr. Chaikin earned a PharmD from the University of Maryland College of Pharmacy, where he also completed a postdoctoral research fellowship in clinical pharmacology. He received his medical degree from New Jersey Medical School and did training in internal medicine at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. He is a fellow of the American College of Clinical Pharmacology and a former member of the society’s Board of Regents.

About NDA Partners

NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact

Earle Martin, Chief Executive Officer

Office: 540-738-2550

MartinEarle@ndapartners.com

Share article on social media or email: